Total Positions
20
Quarter
2025 Q4
Top Holding
PTGX (38.6%)
Top 10 Concentration
98.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-20 of 20
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PTGX
Protagonist The...
|
Healthcare | 38.57% | 32.30% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
2,449,183 | $213,911,643 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBTX
Nanobiotix S.A.
|
Healthcare | 23.44% | 21.09% |
#2
Prev: #2
|
9.4 | no change | no change |
P
S
|
5,623,816 | $130,022,626 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPP
Rapport Therape...
|
Healthcare | 9.76% | 10.52% |
#3
1
Prev: #4
|
3.9 | no change | no change |
P
S
|
1,784,517 | $54,142,246 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MGTX
MeiraGTx Holdin...
|
Healthcare | 9.52% | 10.85% |
#4
1
Prev: #3
|
3.8 | no change | no change |
P
S
|
6,641,064 | $52,796,459 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVRX
CVRx, Inc.
|
Healthcare | 5.15% | 6.57% |
#5
Prev: #5
|
2.1 | -78,569 | -1.9% |
P
S
|
4,024,861 | $28,576,513 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTNM
Contineum Thera...
|
Healthcare | 4.08% | 4.62% |
#6
1
Prev: #7
|
1.6 | no change | no change |
P
S
|
1,979,173 | $22,621,947 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LEGN
Legend Biotech ...
|
Healthcare | 3.19% | 5.27% |
#7
1
Prev: #6
|
1.3 | no change | no change |
P
S
|
814,586 | $17,709,100 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
Xencor, Inc.
|
Healthcare | 2.06% | 1.74% |
#8
1
Prev: #9
|
0.8 | no change | no change |
P
S
|
748,062 | $11,452,829 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRCT
Procept BioRobo...
|
Healthcare | 2.03% | 2.54% |
#9
1
Prev: #8
|
0.8 | no change | no change |
P
S
|
357,939 | $11,260,761 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FATE
Fate Therapeuti...
|
Healthcare | 0.60% | 0.85% |
#10
1
Prev: #11
|
0.2 | no change | no change |
P
S
|
3,379,064 | $3,320,268 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NMRA
Neumora Therape...
|
Healthcare | 0.60% | 0.67% |
#11
1
Prev: #12
|
0.2 | no change | no change |
P
S
|
1,849,445 | $3,310,507 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLYB
Rallybio Corpor...
|
Healthcare | 0.45% | 0.36% |
#12
2
Prev: #14
|
0.2 | no change | no change |
P
S
|
3,636,363 | $2,494,909 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYEL
Lyell Immunopha...
|
Healthcare | 0.23% | 0.13% |
#13
2
Prev: #15
|
0.1 | no change | no change |
P
S
|
41,165 | $1,267,059 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VOR
Vor Biopharma, ...
|
Healthcare | 0.13% | 0.52% |
#14
1
Prev: #13
|
0.1 | no change | no change |
P
S
|
53,732 | $702,815 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NNOX
Nano-X Imaging ...
|
Healthcare | 0.08% | 0.12% |
#15
1
Prev: #16
|
0.0 | no change | no change |
P
S
|
158,852 | $444,786 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LAB
Standard BioToo...
|
Healthcare | 0.07% | 0.08% |
#16
1
Prev: #17
|
0.0 | no change | no change |
P
S
|
311,967 | $399,318 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACET
Adicet Bio, Inc...
|
Healthcare | 0.03% | 0.06% |
#17
1
Prev: #18
|
0.3 | -341,693 | -93.8% |
P
S
|
22,779 | $191,803 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARWR
Arrowhead Pharm...
|
Healthcare | 0.00% | 1.70% |
Sold All 😨
(Was: #10) |
0.3 | -247,598 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
BiomX Inc.
|
—
|
Unknown | 0.00% | 0.01% |
Sold All 😨
(Was: #19) |
0.3 | -96,866 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
SENS
Senseonics Hold...
|
Healthcare | 0.00% | 0.00% |
Sold All 😨
(Was: #20) |
0.3 | -54,621 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-20 of 20 holdings